Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.
about
Complement activation is critical for placental ischemia-induced hypertension in the rat.The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsiaDifferential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.Defective complement inhibitory function predisposes to renal disease.Preeclampsia - will orphan drug status facilitate innovative biological therapies?Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility.Complement factor B activation in patients with preeclampsia.Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.The Salivary Scavenger and Agglutinin (SALSA) in Healthy and Complicated PregnancyLate-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset PreeclampsiaBiomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?Complement Activation in Placental Malaria.Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss.Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.Placental disease and the maternal syndrome of preeclampsia: missing links?The Relationship of Longitudinal Levels of Complement Bb During Pregnancy with Preeclampsia.Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.Estrogens regulate glycosylation of IgG in women and menAdrenomedullin signaling pathway polymorphisms and adverse pregnancy outcomes.CD46 in innate and adaptive immunity: an update.Complement in pregnancy: a delicate balance.Cadmium Handling, Toxicity and Molecular Targets Involved during Pregnancy: Lessons from Experimental Models.Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.Longitudinal characterization of renal proximal tubular markers in normotensive and preeclamptic pregnancies.Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes.PROMISSE: progress in understanding pregnancy complications in patients with SLE.Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia.Complement split product C4d deposition in placenta in systemic lupus erythematosus and pregnancy-induced hypertension.Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.Effect of nicotine on placental ischemia-induced complement activation and hypertension in the rat.Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.Correlations between complement system's activation factors and anti-angiogenesis factors in plasma of patients with early/late-onset severe preeclampsia.Acute Kidney Injury in Pregnancy: The Changing Landscape for the 21st Century.Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case–control studyDisruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia
P2860
Q30409861-B45D0BBD-7EE3-4ECB-AF13-0BBF0E03EDA8Q33431097-D37EBB9A-D56D-4DB6-9D4A-B873D7873BB7Q33767249-7D0C8067-556D-429F-AFE9-6143B140D4F8Q34360684-EF347AF5-57CF-4D16-805A-ED842E77FC1AQ34465747-707E17FA-C6F2-4F0C-BFB3-1655511F16E0Q35124440-CDC136A2-61FE-4399-B7FE-FB2A8277C1A5Q35171916-3AEFF467-9F2D-49D7-BCB3-1C44034463B4Q35587280-39529420-A134-476E-B7D1-DCFA47FBCE1DQ35864583-D6B6AE97-64CE-446C-B9A4-93E901DC68FCQ35909383-6260F62D-DEEB-4033-B9DB-1B52DB0D68C1Q36107337-3B7FE202-60E5-49E2-BC31-49824AC734A5Q36236265-584BC0F0-F455-4577-8FF8-3C7A6A056B35Q36357099-E1BDFD2F-0B2A-4F40-AFF1-7B3A0AEAF835Q36387332-DEF2A2E2-4652-4194-9141-7342CA8E1A45Q36424780-68F73276-5EAC-482A-B240-CEFDEF86F2B7Q36446437-94DABC2E-62FD-41CE-B164-CC9983095B96Q36575544-69F96FBE-6E31-4AE1-8DF2-284F1014B4D6Q37337545-416C7E0B-CFEC-4331-9323-F45E35EBF769Q37486139-6CCFC26F-528B-4B14-BF78-EED98FC2E32CQ37607702-310F9AB0-4851-44CF-A336-B69B5EB6BE07Q37646832-242B1B73-9222-4C5B-BA1E-A88DB932C25EQ37696645-FC089DF2-0102-434E-B7D6-9C13C3324888Q37864688-62345842-A737-46D9-B30D-F266640FC30EQ38038295-249A5602-2918-46E2-813D-4BF0DC0592A0Q38665062-81703657-B070-442A-829B-AB524E0D77BBQ39264755-A703974C-9B11-44DE-BC22-38AF91102E1FQ40229693-39B18F80-84D0-489A-B768-C5670DECA20EQ42670153-A2E0A98B-D67E-45A6-88B6-A85399A4DAC1Q45750632-E5E4A296-6A61-46F7-A486-A2ED15D56685Q46301263-6DB83E59-B49A-49B4-9DEB-0049B8125218Q46493708-29389228-67B4-4112-8C15-698F601E2B0FQ47251151-42B0FF68-278F-4194-A6B7-25B04348E0D3Q47398876-EF01A6A4-F913-4F10-92FE-585D191B30E7Q48164014-397592D8-7927-4B27-8FB1-5A04FC9D41BEQ53717170-065F6E0B-8EB4-418C-BF41-ADB06BB2F263Q55049883-BA8BBB5C-DA78-4730-8BDF-CE671E79E68AQ56449434-8A9A6F3B-73EE-4FB2-897D-75580516EDE0Q56996369-E3D0EFCA-5B34-40A4-B66F-FC512ABA12F2
P2860
Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Dysregulated complement activa ...... other pregnancy complications.
@ast
Dysregulated complement activa ...... other pregnancy complications.
@en
type
label
Dysregulated complement activa ...... other pregnancy complications.
@ast
Dysregulated complement activa ...... other pregnancy complications.
@en
prefLabel
Dysregulated complement activa ...... other pregnancy complications.
@ast
Dysregulated complement activa ...... other pregnancy complications.
@en
P2860
P1433
P1476
Dysregulated complement activa ...... other pregnancy complications.
@en
P2093
P2860
P304
P356
10.1016/J.PLACENTA.2010.03.010
P577
2010-04-27T00:00:00Z